Skip to main content

and
  1. Article

    Open Access

    Availability and use of Standards in vaccine development

    Reference materials are critical in assay development for calibrating and assessing their suitability. The devasting nature of the COVID-19 pandemic and subsequent proliferation of vaccine platforms and techno...

    Michael Selorm Avumegah, Giada Mattiuzzo, Anna Särnefält, Mark Page in npj Vaccines (2023)

  2. Article

    Open Access

    Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience

    The World Health Organization (WHO) guidelines on evaluation of similar biotherapeutic products (SBPs; also called biosimilars) were adopted by the WHO Expert Committee on Biological Standardization (ECBS) in ...

    Pekka Kurki, Hye-Na Kang, Niklas Ekman, Ivana Knezevic, Martina Weise in BioDrugs (2022)

  3. Article

    Open Access

    A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells

    An array of SARS-CoV-2 virus variants have been isolated, propagated and used in in vitro assays, in vivo animal studies and human clinical trials. Observations of working stocks of SARS-CoV-2 suggest that seq...

    Simon G. P. Funnell, Babak Afrough, John James Baczenas, Neil Berry in npj Vaccines (2021)

  4. Article

    Animal models for COVID-19

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronaviru...

    César Muñoz-Fontela, William E. Dowling, Simon G. P. Funnell, Pierre-S. Gsell in Nature (2020)

  5. Article

    Open Access

    WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

    Consultations have been held to promote the revision of the WHO guidelines for assuring the quality and nonclinical safety evaluation of DNA vaccines adopted by the Expert Committee on Biological Standardizati...

    Rebecca Sheets, Hye-Na Kang, Heidi Meyer, Ivana Knezevic in npj Vaccines (2020)

  6. Article

    Open Access

    Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody

    During outbreaks of emerging viruses, such as the Zika outbreak in 2015–2016, speed and accuracy in detection of infection are critical factors to control the spread of the disease; often serological and diagn...

    Giada Mattiuzzo, Ivana Knezevic, Mark Hassall, James Ashall, Sophie Myhill in npj Vaccines (2019)

  7. No Access

    Protocol

    Assuring the Quality and Safety of Vaccines

    Ensuring the consistent safety and efficacy of a vaccine has long been recognized as an essential element in a successful disease-control program. Indeed, the development of appropriate laboratory methods to c...

    Elwyn Griffiths, Ivana Knezevic in Vaccine Protocols (2003)